Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

HAL anticorps (C-Term)

HAL Reactivité: Humain, Souris, Rat WB, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN629752
  • Antigène Voir toutes HAL Anticorps
    HAL (Histidine Ammonia-Lyase (HAL))
    Épitope
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    C-Term
    Reactivité
    • 19
    • 8
    • 7
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    Humain, Souris, Rat
    Hôte
    • 16
    • 3
    Lapin
    Clonalité
    • 18
    • 1
    Polyclonal
    Conjugué
    • 15
    • 2
    • 1
    • 1
    Cet anticorp HAL est non-conjugé
    Application
    • 14
    • 8
    • 6
    • 3
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC)
    Specificité
    HAL antibody was raised against the C terminal of HAL
    Purification
    Purified
    Immunogène
    HAL antibody was raised using the C terminal of HAL corresponding to a region with amino acids EAAHRLLLEQKVWEVAAPYIEKYRMEHIPESRPLSPTAFSLQFLHKKSTK
    Top Product
    Discover our top product HAL Anticorps primaire
  • Indications d'application
    WB: 1.25 µg/mL, IHC: 4-8 µg/mL
    Optimal conditions should be determined by the investigator.
    Commentaires

    HAL Blocking Peptide, catalog no. 33R-2249, is also available for use as a blocking control in assays to test for specificity of this HAL antibody

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Lyophilized powder. Add distilled water for a 1 mg/mL concentration of HAL antibody in PBS
    Concentration
    Lot specific
    Buffer
    PBS
    Conseil sur la manipulation
    Avoid repeated freeze/thaw cycles.
    Dilute only prior to immediate use.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
  • Antigène
    HAL (Histidine Ammonia-Lyase (HAL))
    Autre désignation
    HAL (HAL Produits)
    Synonymes
    anticorps HIS, anticorps HSTD, anticorps hal, anticorps hstd, anticorps xhal, anticorps HAL, anticorps BA3712, anticorps DDBDRAFT_0187742, anticorps DDBDRAFT_0231727, anticorps DDB_0187742, anticorps DDB_0231727, anticorps zgc:136980, anticorps his, anticorps Hsd, anticorps histidase, anticorps histidine ammonia-lyase, anticorps histidine ammonia-lyase, gene 1 L homeolog, anticorps histidine ammonia-lyase HutH, anticorps histidine ammonia-lyase, gene 1, anticorps histidine ammonia lyase, anticorps HAL, anticorps hal.1.L, anticorps hutH, anticorps Tc00.1047053506247.220, anticorps Plav_1493, anticorps hal, anticorps hal.1, anticorps Hal
    Sujet
    HAL is a cytosolic enzyme catalyzing the first reaction in histidine catabolism, the nonoxidative deamination of L-histidine to trans-urocanic acid. HAL defects cause histidinemia which is characterized by increased histidine and histamine and decreased urocanic acid in body fluidsHistidine ammonia-lyase is a cytosolic enzyme catalyzing the first reaction in histidine catabolism, the nonoxidative deamination of L-histidine to trans-urocanic acid. Histidine ammonia-lyase defects cause histidinemia which is characterized by increased histidine and histamine and decreased urocanic acid in body fluids.
    Poids moléculaire
    72 kDa (MW of target protein)
Vous êtes ici:
Support technique